Co-Hosted By:
Join leading scientists, industry experts, and regulatory stakeholders for a two-day in-person workshop on End-to-End Analytical Solutions for mRNA Therapeutics: Supporting Manufacturing and CMC Needs, focused on advancing analytical strategies for mRNA therapeutics.
Explore critical aspects of Chemistry, Manufacturing, and Controls (CMC) for mRNA-based products, with sessions dedicated to raw material qualification, innovative analytical methods, platform technologies, and emerging applications such as cancer vaccines and gene therapies.
This workshop is ideal for professionals involved in mRNA development, manufacturing, and regulatory affairs who are seeking to deepen their understanding of analytical requirements and platform strategies in this rapidly evolving field.
The agenda will include presentations and discussions on:
View the full two-day workshop agenda here.
Cytiva
Untangling the Analytical Complexities of Targeting Lipid Nanoparticles (tLNPs)
ScopeSys Inc.
CLiC Analytical Platform for Single-Particle Multi-Parametric Characterization of mRNA-LNP Therapeutics
Thermo Fisher Scientific
A Mechanistic and Knowledge-Based Perspective on mRNA Manufacturing Processes
BioNTech SE mRNA
mRNA Therapeutics – Last Chance for Platform Methods
Dillico
Rapid and Sequence Independent mRNA Capping Efficiency Method on Oxford Nanopore Platform
Promega Corporation
Development of a Rapid, High-Throughput Luminescent Assay for mRNA 5′ Capping Efficiency
Sanofi
Platform-Based Analytical Strategies to Accelerate mRNA-LNP Product Development: Applicability and Case Studies
Yamout Chem Consulting
Assessing the Correlation Between Physical and Functional Characterization of mRNA
National Institute of Standards and Technology
Comparability of Analytical Techniques that Assess mRNA Drug-Substance CQAs: NIST RGTM 10202 FLuc mRNA
Waters Corporation
Advances in mRNA Analysis with Liquid Chromatography Methods
Refeyn
Mass Photometry as a Multiple-Attribute Tool for mRNA Therapeutic Development
Molgenium
A Novel RIG I Based Assay for Quantitative Detection of dsRNA Contaminants in RNA Therapeutics
USP, Global Biologics
Building mRNA Quality: The USP Standards Approach
Replicate Bioscience
Development and Qualification of a Dual-Parameter Potency Assay for a Phase I Clinical Self-Replicating RNA (srRNA)
Johns Hopkins University
Messenger RNA and Guide RNA Distributions in Lipid Nanoparticles Impact Gene Editing Efficiency In Vivo: A Framework for RNA LNP Rational Design Guided by Single-Particle Attributes
Pfizer
DNA Starting Material Control Strategy
Eclipsebio
Integrating Sequencing Analytics into mRNA Manufacturing and Quality Control
Replicate Bioscience
Development and Qualification of a Dual-Parameter Potency Assay for a Phase I Clinical Self-Replicating RNA (srRNA)
Johns Hopkins University
Messenger RNA and Guide RNA Distributions in Lipid Nanoparticles Impact Gene Editing Efficiency In Vivo: A Framework for RNA LNP Rational Design Guided by Single-Particle Attributes
Pfizer
DNA Starting Material Control Strategy
Hear scientific presentations on cutting-edge analytical methods and CQA assessment
Gain insights into the correlation between physical and functional characteristics of mRNA products
Explore applications of mRNA across diverse therapeutic modalities
Contribute as a speaker through abstract submission
